Perlegen and GlaxoSmithKline Enter New Pharmacogenomics Collaboration | GenomeWeb

NEW YORK, Oct. 12 (GenomeWeb News) - Perlegen Sciences said today that it will commence a high-density whole-genome scanning project with GlaxoSmithKline for the purposes of determining genetic variants associated with a specific GSK trait of interest, the second such collaboration between the companies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.